Cacna1c-flox Mouse
一般名
Cacna1c-flox
製品ID
S-CKO-01488
背景情報
C57BL/6JCya
系統ID
CKOCMP-12288-Cacna1c-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Cacna1c-flox Mouse(カタログ番号S-CKO-01488)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Cacna1c-flox
系統ID
CKOCMP-12288-Cacna1c-B6J-VA
遺伝子名
製品ID
S-CKO-01488
遺伝子別名
MBC, Cav1.2, Cchl1a1, MELC-CC, D930026N18Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 6
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000112793
NCBIトランスクリプトID
NM_001256002
ターゲット領域
Exon 2
有効領域の大きさ
~2.0 kb
遺伝子研究の概要
CACNA1C encodes the pore-forming subunit of the CaV1.2 L-type Ca2+ channel, a crucial component in membrane physiology across multiple tissues like the heart, brain, and immune system [1]. This channel is involved in various cellular functions, and the gene's role is of great biological importance in understanding physiological and pathological processes. Genetic models, such as gene knockout (KO) or conditional knockout (CKO) mouse models, can be valuable for studying CACNA1C.
Mutations in CACNA1C can lead to a wide range of disorders. Timothy syndrome (TS), a severe multisystem disorder, is characterized by neurodevelopmental deficits, long-QT syndrome, cardiac arrhythmias, craniofacial abnormalities, and immune deficits [1]. Additionally, CACNA1C-related disorders can present with more selective phenotypes, such as predominantly cardiac or neurological symptoms. Some individuals with heterozygous variants in CACNA1C show neurological manifestations like developmental delays, intellectual disability, autism, hypotonia, ataxia, and epilepsy [2]. Functional studies of missense variants via patch-clamp experiments demonstrated differential effects on channel function in vitro, including loss of function, neutral effect, and gain of function [2]. Large-scale genome-wide association studies have shown that genetic variation in CACNA1C increases the risk for psychiatric disorders, and research has focused on uncovering the underlying biological mechanisms [3]. Meta-analyses suggest that CACNA1C (rs1006737) may be a susceptibility gene for schizophrenia [4]. Pharmacoepidemiological evidence indicates that calcium channel blockers targeting L-type calcium channels (LTCCs) encoded by CACNA1C might have beneficial effects on the onset or course of psychiatric disorders [5]. Also, CACNA1C-rs1006737 polymorphisms are slightly associated with cognitive performance in severe mental disorders [6]. In ovarian cancer, CACNA1C has lower expression in tumor tissues, is an independent risk factor of overall survival, and is associated with immunity [7].
In conclusion, CACNA1C is essential for membrane physiology in multiple tissues. Model-based research, such as KO or CKO mouse models (not directly described in provided references but emphasized as valuable approach), could potentially further clarify its role in various disease areas including multisystem disorders, neurological and psychiatric conditions, and ovarian cancer. Understanding CACNA1C is crucial for unravelling the mechanisms of these diseases and may offer new directions for treatment.
References:
1. Herold, Kevin G, Hussey, John W, Dick, Ivy E. . CACNA1C-Related Channelopathies. In Handbook of experimental pharmacology, 279, 159-181. doi:10.1007/164_2022_624. https://pubmed.ncbi.nlm.nih.gov/36598608/
2. Rodan, Lance H, Spillmann, Rebecca C, Kurata, Harley T, Au, Ping Yee Billie, Shashi, Vandana. 2021. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations. In Genetics in medicine : official journal of the American College of Medical Genetics, 23, 1922-1932. doi:10.1038/s41436-021-01232-8. https://pubmed.ncbi.nlm.nih.gov/34163037/
3. Moon, Anna L, Haan, Niels, Wilkinson, Lawrence S, Thomas, Kerrie L, Hall, Jeremy. . CACNA1C: Association With Psychiatric Disorders, Behavior, and Neurogenesis. In Schizophrenia bulletin, 44, 958-965. doi:10.1093/schbul/sby096. https://pubmed.ncbi.nlm.nih.gov/29982775/
4. Zhu, Dongjian, Yin, Jingwen, Liang, Chunmei, Wang, Yajun, Ma, Guoda. 2019. CACNA1C (rs1006737) may be a susceptibility gene for schizophrenia: An updated meta-analysis. In Brain and behavior, 9, e01292. doi:10.1002/brb3.1292. https://pubmed.ncbi.nlm.nih.gov/31033230/
5. Harrison, Paul J, Husain, Syed M, Lee, Hami, Haerty, Wilfried, Tunbridge, Elizabeth M. 2022. CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology. In Neuropharmacology, 220, 109262. doi:10.1016/j.neuropharm.2022.109262. https://pubmed.ncbi.nlm.nih.gov/36154842/
6. Novaes de Oliveira Roldan, Ana Cecília, Fernandes Júnior, Luiz Carlos Cantanhede, de Oliveira, Carlos Eduardo Coral, Nunes, Sandra Odebrecht Vargas. 2022. Impact of ZNF804A rs1344706 or CACNA1C rs1006737 polymorphisms on cognition in patients with severe mental disorders: A systematic review and meta-analysis. In The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 24, 195-208. doi:10.1080/15622975.2022.2097308. https://pubmed.ncbi.nlm.nih.gov/35786202/
7. Chang, Xiaohan, Dong, Yunxia. 2021. CACNA1C is a prognostic predictor for patients with ovarian cancer. In Journal of ovarian research, 14, 88. doi:10.1186/s13048-021-00830-z. https://pubmed.ncbi.nlm.nih.gov/34210324/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
